Literature DB >> 29336283

Headaches and facial pain in rhinology.

Asitha D L Jayawardena1, Rakesh Chandra1.   

Abstract

"Sinus headache" is a common chief complaint that often leads patients to an otolaryngologist's office. Because facial pain may or may not be sinogenic in origin, the otolaryngologist should be equipped to evaluate and treat or to appropriately refer these patients. Analysis of current data indicates that the majority of patients who present with sinus headaches actually have migraines. Furthermore, the downstream effect of the cytokine cascade initiated in migraine physiology can cause rhinologic symptoms, including rhinorrhea, congestion, and lacrimation, which may also confound diagnosis. Other causes of sinus headache include the following: cluster headaches, Sluder neuralgia, trigeminal neuralgia, myofascial trigger point pain (tension headaches, temporomandibular joint dysfunction), and contact point headaches. The diagnostic dilemma for an otolaryngologist occurs when a patient has facial pain and symptoms that may indicate chronic rhinosinusitis but with nondiagnostic endoscopy. Traditionally, these patients have been primarily managed with empiric antibiotics. An alternative strategy is to first screen these patients with an upfront computed tomography. This algorithm may ultimately decrease cost; avert unnecessary antibiotics prescriptions; and prompt more timely referrals to other, more appropriate, disciplines, such as neurology, dentistry, and/or pain management specialists.

Entities:  

Mesh:

Year:  2018        PMID: 29336283     DOI: 10.2500/ajra.2018.32.4501

Source DB:  PubMed          Journal:  Am J Rhinol Allergy        ISSN: 1945-8932            Impact factor:   2.467


  2 in total

Review 1.  Prevalence of pain due to rhinosinusitis: a review.

Authors:  Carlotta Pipolo; Alberto Maria Saibene; Giovanni Felisati
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

Review 2.  Debunking Myths: Sinus Headache.

Authors:  Jennifer Robblee; Karissa A Secora
Journal:  Curr Neurol Neurosci Rep       Date:  2021-06-20       Impact factor: 5.081

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.